VirtueDX
Localized Innovation for Global Diagnostics
Founded 2019 · $130.0M raised
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- virtuedx.com
- Total Funding
- $130.0M
- Last Round
- $100.0M Series BJan 2022
- Rounds
- 2
About
Virtue Diagnostics (VirtueDX) is a global in vitro diagnostics company founded in 2019, committed to platform innovation in emerging markets. The company specializes in chemiluminescence, clinical chemistry, hematology, mass spectrometry, multiplex immunohistochemistry (mIHC), and molecular diagnostics across infectious disease, cancer, and chronic conditions. With a 12,000 square meter manufacturing site established in 2022, Virtue Diagnostics operates across China, Singapore, Indonesia, and Brazil, including its subsidiary Labtest — a leading IVD company in Brazil with over 50 years of history acquired in 2022.
Summary
VirtueDX is a Biotech company, founded in 2019. It has raised $130.0M in total across 2 rounds, most recently a $100.0M Series B round in Jan 2022. Investors include Sequoia Capital, Morningside Group and Lilly Asia Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/virtuedx"><img src="https://indexed.vc/api/badge/company/virtuedx" alt="VirtueDX on Indexed.vc" width="260" height="76" /></a>